NO154522C - Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.

Info

Publication number
NO154522C
NO154522C NO793469A NO793469A NO154522C NO 154522 C NO154522 C NO 154522C NO 793469 A NO793469 A NO 793469A NO 793469 A NO793469 A NO 793469A NO 154522 C NO154522 C NO 154522C
Authority
NO
Norway
Prior art keywords
preparation
therapeutically effective
analogy procedure
chinoline derivatives
chinoline
Prior art date
Application number
NO793469A
Other languages
English (en)
Other versions
NO793469L (no
NO154522B (no
Inventor
David Cox
Hugh Cairns
Nigel Chadwick
John Louis Suschitzky
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of NO793469L publication Critical patent/NO793469L/no
Priority to NO852258A priority Critical patent/NO156692C/no
Publication of NO154522B publication Critical patent/NO154522B/no
Publication of NO154522C publication Critical patent/NO154522C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO793469A 1978-10-31 1979-10-29 Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater. NO154522C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO852258A NO156692C (no) 1978-10-31 1985-06-04 Mellomprodukter for bruk ved fremstilling av terapeutisk virksomme kinolinderivater.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7842679 1978-10-31
GB7920760 1979-06-14

Publications (3)

Publication Number Publication Date
NO793469L NO793469L (no) 1980-05-02
NO154522B NO154522B (no) 1986-06-30
NO154522C true NO154522C (no) 1986-10-08

Family

ID=26269406

Family Applications (1)

Application Number Title Priority Date Filing Date
NO793469A NO154522C (no) 1978-10-31 1979-10-29 Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.

Country Status (32)

Country Link
US (1) US4419352A (no)
AR (1) AR230449A1 (no)
AT (1) AT379811B (no)
AU (1) AU528648B2 (no)
BR (1) BR7907006A (no)
CA (1) CA1142520A (no)
CH (1) CH643264A5 (no)
CS (1) CS231166B2 (no)
CU (1) CU21123A (no)
DD (1) DD146954A5 (no)
DE (1) DE2943658A1 (no)
DK (1) DK458679A (no)
FI (1) FI67702C (no)
FR (1) FR2440371A1 (no)
GR (1) GR73861B (no)
HK (1) HK66185A (no)
HU (1) HU183087B (no)
IE (1) IE49464B1 (no)
IL (1) IL58579A (no)
KE (1) KE3540A (no)
LU (1) LU81841A1 (no)
MA (1) MA18631A1 (no)
MY (1) MY8500439A (no)
NL (1) NL7907916A (no)
NO (1) NO154522C (no)
NZ (1) NZ191956A (no)
PH (1) PH15442A (no)
PL (1) PL130691B1 (no)
PT (1) PT70392A (no)
SE (1) SE451071B (no)
SG (1) SG40885G (no)
SU (1) SU1014476A3 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260306A (en) * 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
GB8402047D0 (en) * 1984-01-26 1984-02-29 Fisons Plc Nitrogen heterocycles
DE3584580D1 (de) * 1984-04-13 1991-12-12 Fisons Plc Formen und formulierungen des nedocromil-natriumsalzes.
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
NL8701335A (nl) * 1986-06-21 1988-01-18 Sandoz Ag Orale farmaceutische preparaten.
USRE38628E1 (en) * 1986-12-23 2004-10-19 Fisons Plc Pharmaceutical compositions
ES2058129T3 (es) * 1986-12-23 1994-11-01 Fisons Plc Composiciones farmaceuticas que comprenden una solucion acuosa de un derivado de piranoquinolina.
USH672H (en) 1986-12-31 1989-09-05 E. R. Squibb & Sons, Inc. Stable antifungal capsule formulation
US4767612A (en) * 1987-01-23 1988-08-30 Rorer Pharmaceutical Corporation Triamcinolone acetonide for the treatment of allergic rhinitis
GB8704089D0 (en) * 1987-02-21 1987-03-25 Fisons Plc Method of treatment
EP0294914A3 (en) * 1987-03-17 1990-10-10 FISONS plc Nedocromil for the treatment of dermatological disorders
US5648084A (en) * 1990-02-28 1997-07-15 Guttag; Alvin Multiple dosage medicine drop bottle
EP0546177B1 (en) * 1990-07-25 1998-01-07 Teijin Limited Benzopyran derivative, production thereof, and pharmaceutical composition containing the same
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
US5453431A (en) * 1993-10-29 1995-09-26 Gilman; Andrew L. Use of hydroxychloroquine for treatment of graft-versus-host disease
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US5989571A (en) * 1997-07-23 1999-11-23 Millenium Pharmaceutical Technologies, Inc. Contact dermatitis pharmaceutical preparation with anti-histamine and anti-inflammatory
US5885550A (en) * 1998-07-02 1999-03-23 Vallier; Deandra K. Ophthalmic whitening solution
US7101547B1 (en) 1999-01-22 2006-09-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance P by using anti-substance P antibodies
EP1284972A1 (en) * 2000-05-17 2003-02-26 Cor Therapeutics, Inc. Methods for producing amino substituted chromanes and intermediates therefor
US9132116B2 (en) 2004-08-02 2015-09-15 Willowcroft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis
GB0524808D0 (en) * 2005-12-05 2006-01-11 Novartis Ag Organic compounds
DE102007028095A1 (de) * 2007-06-19 2009-01-15 Bachmann, Vincent Zubereitung zur Behandlung von Hufrehe bei Equiden
FR2924344B1 (fr) * 2007-12-04 2010-04-16 Pf Medicament Utilisation de la mequitazine sous la forme de racemate ou d'enantiomeres pour la preparation d'un medicament destine au traitement ou a la prevention de pathologies impliquant les recepteurs histaminiques h4.
EP2424527B8 (en) * 2009-04-29 2019-07-17 Willowcraft Pharm Inc. Mast cell stabilizers to prevent or treat laminitis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1504709A (en) * 1974-12-07 1978-03-22 Fisons Ltd N-substituted quinolinone-2-carboxyl. acid der
US4143042A (en) * 1977-03-08 1979-03-06 Takeda Chemical Industries, Ltd. 1-azaxanthone-3-carboxylic acids
IL54614A (en) * 1977-05-04 1983-07-31 Fisons Ltd Dihydrodioxo-pyranoquinoline dicarboxylic acid derivatives,their production and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FR2440371A1 (fr) 1980-05-30
HK66185A (en) 1985-09-13
IL58579A0 (en) 1980-01-31
NZ191956A (en) 1984-05-31
FI67702B (fi) 1985-01-31
FI67702C (fi) 1985-05-10
PH15442A (en) 1983-01-18
PL130691B1 (en) 1984-08-31
MY8500439A (en) 1985-12-31
PT70392A (en) 1979-11-01
FI793369A (fi) 1980-05-01
PL219304A1 (no) 1980-12-01
NO793469L (no) 1980-05-02
CS735979A2 (en) 1984-02-13
DE2943658C2 (no) 1991-08-01
CA1142520A (en) 1983-03-08
GR73861B (no) 1984-05-08
LU81841A1 (fr) 1980-05-07
DK458679A (da) 1980-05-01
IE792074L (en) 1980-04-30
HU183087B (en) 1984-04-28
FR2440371B1 (no) 1983-01-28
IL58579A (en) 1985-12-31
NL7907916A (nl) 1980-05-02
ATA701479A (de) 1985-07-15
SG40885G (en) 1986-05-02
AU5228779A (en) 1980-05-08
CU21123A (es) 1982-08-28
AR230449A1 (es) 1984-04-30
US4419352A (en) 1983-12-06
SU1014476A3 (ru) 1983-04-23
MA18631A1 (fr) 1980-07-01
AU528648B2 (en) 1983-05-05
BR7907006A (pt) 1980-07-15
SE7908995L (sv) 1980-05-01
DD146954A5 (de) 1981-03-11
IE49464B1 (en) 1985-10-16
DE2943658A1 (de) 1980-05-14
CS231166B2 (en) 1984-10-15
SE451071B (sv) 1987-08-31
AT379811B (de) 1986-03-10
NO154522B (no) 1986-06-30
KE3540A (en) 1985-07-12
CH643264A5 (fr) 1984-05-30

Similar Documents

Publication Publication Date Title
NO154522C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme kinolinderivater.
NO152935C (no) Analogifremgangsmaate for fremstilling av anti-inflammatorisk virksomme tioetiansyrederivater.
NO153177C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive tetrazolylalkoksy-karbostyrilderivater.
NO151588C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamid-derivater
NO790358L (no) Fremgangsmaate for fremstilling av alkylendiaminderivater
NO151321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater
NO153136C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive naftyridinderivater.
NO794069L (no) Fremgangsmaate ved fremstilling av terapeutisk virksomme imidayolderivater.
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
NO153569C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive merkaptoacetyl-prolin-derivater.
NO792404L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO151088C (no) Analogifremgangsmaate til fremstilling av farmakologisk virksomme silyl-glucosaminderivater
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO150081C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme derivater av perhydro-aza-heterocykler
NO791139L (no) Fremgangsmaate for fremstilling av lysergolderivater
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO146356C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkanolaminderivater
NO151285C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive di-o-n-alkyl-glycerolderivater
NO147716C (no) Analogifremgangsmaate for fremstilling av antibakterielle erytromycylaminderivater.
NO156865B (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolderivater.
NO148673C (no) Analogifremgangsmaate ved fremstilling av farmakologisk virksomme tiofenderivater
NO148454C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater
NO151196C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme fluorerte alkenylendiaminderivater
NO155539C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme isokinolinderivater.
NO151660C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazolderivater.